Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study

NCT01558011 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
51
Enrollment
OTHER
Sponsor class

Stopped The budget issues.

Conditions

Interventions

Sponsor

National Health Research Institutes, Taiwan

Collaborators